These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21953638)

  • 1. Extracellular proteolysis in macrophage migration: losing grip for a breakthrough.
    Vérollet C; Charrière GM; Labrousse A; Cougoule C; Le Cabec V; Maridonneau-Parini I
    Eur J Immunol; 2011 Oct; 41(10):2805-13. PubMed ID: 21953638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures.
    Van Goethem E; Poincloux R; Gauffre F; Maridonneau-Parini I; Le Cabec V
    J Immunol; 2010 Jan; 184(2):1049-61. PubMed ID: 20018633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development.
    Tomlinson ML; Garcia-Morales C; Abu-Elmagd M; Wheeler GN
    Mech Dev; 2008; 125(11-12):1059-70. PubMed ID: 18684398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in 3D environments.
    Cougoule C; Van Goethem E; Le Cabec V; Lafouresse F; Dupré L; Mehraj V; Mège JL; Lastrucci C; Maridonneau-Parini I
    Eur J Cell Biol; 2012; 91(11-12):938-49. PubMed ID: 22999511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of macrophage 3D migration: a therapeutic challenge to limit tissue infiltration.
    Maridonneau-Parini I
    Immunol Rev; 2014 Nov; 262(1):216-31. PubMed ID: 25319337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
    Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
    Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of proteases as anticancer drugs.
    Jedinak A; Maliar T
    Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.
    Krstić J; Obradović H; Jauković A; Okić-Đorđević I; Trivanović D; Kukolj T; Mojsilović S; Ilić V; Santibañez JF; Bugarski D
    Biochim Biophys Acta; 2015 Feb; 1853(2):431-44. PubMed ID: 25433194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
    Pliyev BK; Antonova OA; Menshikov M
    Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The macrophage and fibrinolysis.
    Loscalzo J
    Semin Thromb Hemost; 1996; 22(6):503-6. PubMed ID: 9122715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of emmprin/CD147 in tissue remodeling.
    Huet E; Gabison EE; Mourah S; Menashi S
    Connect Tissue Res; 2008; 49(3):175-9. PubMed ID: 18661337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pericellular proteases in angiogenesis and vasculogenesis.
    van Hinsbergh VW; Engelse MA; Quax PH
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):716-28. PubMed ID: 16469948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phagocyte migration: an overview].
    Le Cabec V; Van Goethem E; Guiet R; Maridonneau-Parini I
    Med Sci (Paris); 2011 Dec; 27(12):1112-9. PubMed ID: 22192751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl-LDL stimulates macrophage-dependent plasminogen activation and degradation of extracellular matrix.
    Falcone DJ; Ferenc MJ
    J Cell Physiol; 1988 Jun; 135(3):387-96. PubMed ID: 3397384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the extracellular matrix in lymphocyte migration.
    Korpos E; Wu C; Song J; Hallmann R; Sorokin L
    Cell Tissue Res; 2010 Jan; 339(1):47-57. PubMed ID: 19697064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of tissue plasminogen activator gene reduces macrophage migration.
    Ling C; Zou T; Hsiao Y; Tao X; Chen ZL; Strickland S; Song H
    Biochem Biophys Res Commun; 2006 Oct; 349(3):906-12. PubMed ID: 16978586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage podosomes go 3D.
    Van Goethem E; Guiet R; Balor S; Charrière GM; Poincloux R; Labrousse A; Maridonneau-Parini I; Le Cabec V
    Eur J Cell Biol; 2011; 90(2-3):224-36. PubMed ID: 20801545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
    Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
    J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix determinants of proteolytic and non-proteolytic cell migration.
    Wolf K; Friedl P
    Trends Cell Biol; 2011 Dec; 21(12):736-44. PubMed ID: 22036198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.